Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.34B 14.11M 12.2M 11.4M 10.45M 19.66M 19.97M 134M 52.48M 673M 52.98M 51.82M 2.22B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.75B 18.43M 15.94M 14.88M 13.65M 25.68M 26.09M 175M 68.54M 879M 69.2M 67.68M 2.91B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day+0.50%
1 week+1.76%
Current month+1.76%
1 month+1.97%
3 months-14.73%
6 months+6.34%
Current year-9.49%
1 week 23.67
Extreme 23.67
25.4
1 month 23
Extreme 23
25.5
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
52
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%+1.76%-46.91%-72.70% 14.11M
-0.21%+1.56%+31.11%+105.95% 101B
-0.53%+2.77%+54.10%+156.34% 55.37B
-0.33%+1.36%+4.20%+277.22% 24.21B
+1.64%-0.95%-12.52%-13.11% 8.29B
+4.21%-0.41%-32.64%-25.72% 7.53B
-0.82%-2.42%-9.64%-18.66% 6.75B
+0.14%+0.19%+19.41%+18.80% 6.19B
-1.85%-4.36%-3.92%+19.39% 5.07B
+0.81%-3.11%-6.20%-5.73% 3.69B
Average +0.36%-0.14%-0.30%+44.18% 21.85B
Weighted average by Cap. -0.11%+1.38%+27.06%+118.42%

Financials

2025 2026
Net sales 2.93B 30.74M 26.59M 24.83M 22.78M 42.84M 43.53M 291M 114M 1.47B 115M 113M 4.85B 2.7B 28.39M 24.56M 22.93M 21.04M 39.57M 40.19M 269M 106M 1.35B 107M 104M 4.48B
Net income 251M 2.63M 2.28M 2.13M 1.95M 3.67M 3.73M 24.97M 9.8M 126M 9.89M 9.68M 415M 14.17M 149K 129K 120K 110K 208K 211K 1.41M 554K 7.1M 559K 547K 23.48M
Net Debt 127M 1.34M 1.16M 1.08M 991K 1.86M 1.89M 12.67M 4.97M 63.77M 5.02M 4.91M 211M 411M 4.32M 3.74M 3.49M 3.2M 6.02M 6.12M 40.93M 16.07M 206M 16.22M 15.86M 681M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
26-08-07 ₹24.32 +0.50% 16,200
26-08-06 ₹24.20 +0.12% 35,022
26-08-05 ₹24.17 +0.58% 90,450
26-08-04 ₹24.03 +0.13% 23,587
26-08-03 ₹24.00 +0.42% 13,887
  1. Stock Market
  2. Stocks
  3. BALAXI Stock